9th Sep 2009 16:26
CELSIS INTERNATIONAL PLC
("Celsis", "the Company" or "the Group")
Notice of application of cancellation of Listing
9 September 2009: Celsis International plc, the life sciences products and laboratory services company, today announces that following the announcement earlier today that Nastor Investments Limited ("Nastor Investments") either owned or had received valid acceptances in respect of, in aggregate, 16,513,640 Celsis Shares, carrying approximately 75.4 per cent. of voting rights attached to the existing issued share capital of Celsis and that as a result, Nastor Investments would now procure the making of an application by Celsis for the cancellation of the listing of Celsis Shares on the Official List and the admission to trading of Celsis Shares on the London Stock Exchange, Celsis has made an application for the cancellation of the listing of Celsis Shares on the Official List and the admission to trading of Celsis Shares on the London Stock Exchange.
It is anticipated that cancellation of the Celsis listing and admission to trading will take effect on 8 October 2009, being the required notice period, such notice period having now commenced, of not less than 20 business days following the date of this announcement.
General
Terms used in this announcement shall have the meaning given to them in the Offer Document dated 10 August 2009, unless the context requires otherwise.
In accordance with Rule 19.11 of the City Code, a copy of this announcement will be published on the following websites: www.navalue.co.uk/site/literature/NASTOR/ and www.celsis.com/about-our-company/news-room/financial-news/2009/.
Copies of the Offer Document and Form of Acceptance will be available from the offices of Capita Registrars, Corporate Actions, The Registry, 34 Beckenham Road, Beckenham, Kent BR3 4TU. The Offer Document may also be obtained from the website of Celsis, www. celsis.com/about-our-company/news-room/financial-news/2009/.
PRESS ENQUIRIES
For further information contact:
|
Enquiries: |
|
|
Celsis International plc |
Tel: 01223 598 428 |
|
Jay LeCoque |
|
|
Robyn LaLonde |
|
|
Nomura Code Securities |
Tel: 020 7776 1200 |
|
Chris Collins |
|
|
Phil Walker |
|
|
Financial Dynamics |
Tel: 020 7831 3113 |
|
Jonathan Birt |
|
|
Susan Quigley |
This announcement does not constitute, or form part of, any offer for, or any solicitation of any offer for, securities. Any response to the Offer should be made only on the basis of information referred to in the Offer Document which Nastor Investments sent to Celsis Shareholders and, for information only, to holders of options under the Celsis Share Schemes on 10 August 2009.
The availability of the Offer to persons who are not resident in the United Kingdom may be affected by the laws of the relevant jurisdiction in which they are located. Such persons should inform themselves of, and observe, any applicable legal or regulatory requirements of their jurisdiction. Any failure to comply with these requirements may constitute a violation of the securities laws at any such jurisdiction. Further details in relation to overseas shareholders are contained in the Offer Document.
The Offer referred to in this announcement is not being made available directly or indirectly, in, into or by use of the mails of, or by any means or instrumentality (including, without limitation, telephonically or electronically) or interstate or foreign commerce of, or any facilities of a nationals securities exchange of, the United States, Canada, Australia or Japan or any other jurisdiction if to do so would constitute a violation of the relevant laws of such jurisdiction. This announcement does not constitute an offer in the United States, Canada, Australia or Japan or any such other jurisdiction and the Offer is being made available by any such use, means, instrumentality or facilities or otherwise from or within the United States, Canada, Australia or Japan or any such other jurisdiction. Accordingly this announcement is not being, and should not be, mailed, transmitted or otherwise distributed, in whole or in part, in or into or from the United States, Canada, Australia or Japan or any such other jurisdiction.
Related Shares:
Celadon PharmaceuticalsNorth Atl.smlrOryx International Growth